Clarkson Disease

Clarkson disease is a very rare disorder where fluid and proteins suddenly leak out of tiny blood vessels (capillaries) into the body’s tissues. During an attack, blood pressure drops, the blood becomes thick (because plasma leaves the vessels), and the level of the main blood protein (albumin) falls. This “triad” (low blood pressure, hemoconcentration, low albumin) helps doctors recognize the disease. Episodes can be severe but are often reversible with fast, careful care. American College of Physicians Journals+2PubMed+2

Clarkson disease—also called idiopathic systemic capillary leak syndrome (ISCLS)—is a very rare condition in which the tiny blood vessels (capillaries) suddenly become leaky. Plasma (the fluid part of blood) and proteins move out of the bloodstream into tissues. This causes a rapid drop in blood pressure, thickening of the blood (hemoconcentration), very low albumin, swelling of arms and legs, and risk of shock and organ injury. Attacks often have two phases: an initial “leak phase” (low blood pressure, cold limbs, low urine) and a later “recruitment phase” when fluid rushes back into the bloodstream and can cause sudden pulmonary edema. Many adults have an associated monoclonal gammopathy (often IgG-κ). Between attacks, people may feel normal. Early recognition and careful fluid/ICU management save lives. PMC+3PMC+3PubMed+3

Clarkson disease is a rare, repeating illness where, for short periods, capillaries all over the body become loose and let fluid and large proteins escape into the tissues. Because fluid leaves the bloodstream, the person becomes dry inside the blood vessels (low circulating volume). Blood pressure falls. The blood looks “thick” on tests because the liquid part is missing. Albumin drops because it leaks out. After the leak stops, the trapped fluid can return to the circulation, which sometimes causes swelling or even fluid overload if too much IV fluid was given earlier. American College of Physicians Journals+1

Doctors first described the syndrome in the 1960s, and it was later named after Dr. Bayard Clarkson. Since then, reviews and case series have explained its typical signs, phases, and ways to diagnose and prevent attacks. PubMed+1

Other names

Clarkson disease is known by several names in the medical literature. These all point to the same condition:

• Idiopathic systemic capillary leak syndrome (ISCLS)

• Systemic capillary leak syndrome (SCLS)

• Capillary hyperpermeability syndrome

• Primary capillary leak syndrome
  All of these terms describe sudden, reversible capillary “leaks” not caused by heart failure or kidney failure. Orphanet and rare-disease resources list these synonyms. Orpha+2Orpha+2

Types

1. Idiopathic/primary Clarkson disease (the classic form):
   This is the most common form. No clear external cause is found. Many adults with this form have a small abnormal protein in the blood called a monoclonal gammopathy (often IgG-κ MGUS). This protein is a marker that often travels with the disease and may be a clue in diagnosis. American College of Physicians Journals

2. Secondary capillary leak (capillary leak due to another problem):
   Sometimes similar “leak” episodes happen because of another illness or drug (for example, severe infection, certain cancer drugs, or high-dose interleukin-2 therapy). These are not idiopathic Clarkson disease but can look similar. It is important to rule these out. ATS Journals

3. Pediatric presentations and variants:
   Children can rarely develop an ISCLS-like picture. The same triad appears, but the triggers, risks, and course can differ by age, so careful specialist evaluation is needed. Rare Diseases Journal

The three clinical phases

• Prodrome (warning phase): Many patients feel unwell for a day or two before the leak. They may have fever, stomach pain, body aches, or a recent cold. These nonspecific signals can help with early recognition. Yale School of Medicine

• Leak phase (shock phase): Blood pressure falls. Hands and feet swell. Weight may rise quickly from fluid shifting into tissues. Lab tests show hemoconcentration (high hematocrit), low albumin, and sometimes rising creatinine from kidney under-perfusion. American College of Physicians Journals+1

• Post-leak phase (recovery phase): Leaky vessels tighten again. Fluid trapped in tissues re-enters the bloodstream. If too much IV fluid was given earlier, this return can overload the heart and lungs. Doctors therefore replace fluids carefully and monitor closely. PMC

Causes

Clarkson disease (idiopathic SCLS) has no single proven cause, but many associations and triggers are reported. Doctors also must exclude “secondary” causes that mimic it. Here are 20 important items, explained simply:

1. Idiopathic endothelial dysfunction: The capillary lining (endothelium) becomes abnormally “leaky” during attacks for reasons not fully known. Research suggests circulating factors during episodes can trigger this leak. PubMed

2. Monoclonal gammopathy (MGUS, often IgG-κ): A small, abnormal antibody protein is common in adults with ISCLS and may play a role or be a marker. American College of Physicians Journals

3. Recent viral illness (e.g., flu-like infection): Many patients report a cold or fever before attacks. Viral inflammation may trigger endothelium changes. Yale School of Medicine

4. Physical stress or overexertion: Heavy exertion can precede some attacks, likely through stress hormones and endothelial effects. (Clinical reviews note nonspecific stressors as triggers.) American College of Physicians Journals

5. Dehydration: Low intravascular volume may worsen the fall in blood pressure during the leak. (Supportive care literature emphasizes careful volume management.) American College of Physicians Journals

6. Secondary to severe infection/sepsis (not idiopathic): Sepsis can cause a similar capillary leak; it must be ruled out in every suspected case. ATS Journals

7. Secondary to viral hemorrhagic fevers (not idiopathic): Some hemorrhagic viruses cause profound endothelial leak and shock. This is a different category but looks similar. scivisionpub.com

8. Secondary to high-dose interleukin-2 therapy (not idiopathic): Known to produce a capillary leak–like picture during cancer immunotherapy. ATS Journals

9. Secondary to granulocyte colony-stimulating factor, interferon, or other biologics (not idiopathic): Reported drug-related leaks can mimic attacks. ATS Journals

10. Secondary to certain chemotherapies (e.g., gemcitabine) (not idiopathic): Several anticancer drugs have case reports of capillary leak. Excluding drug causes is key. ATS Journals

11. Allergic-type inflammatory bursts: Reviews propose immune mediators can briefly open endothelial junctions. (Mechanistic letters and reviews discuss this.) ATS Journals

12. Cytokine surges: High levels of inflammatory cytokines during prodrome may disturb capillary barriers. PubMed

13. Cold exposure or weather changes (reported anecdotally): Some patients notice seasonal clustering; mechanisms are unclear. (Mentioned in clinical narratives.) American College of Physicians Journals

14. Bacterial infections (not idiopathic): Like sepsis, severe bacterial infections can cause secondary leak and must be excluded. ATS Journals

15. Anaphylactoid reactions (not idiopathic): Massive histamine release can mimic SCLS physiology; careful history helps differentiate. American College of Physicians Journals

16. Autoimmune activation (theory): Some research explores autoantibodies or immune dysregulation during attacks. The exact role is still being studied. PubMed

17. Endothelial toxins in circulation (hypothesis): Classic work showed patient plasma during attacks could transfer a shock-like state in animal models, supporting a circulating factor. PubMed

18. Pediatric immune triggers: In children, infections and immune shifts are often suspected; data are limited. Rare Diseases Journal

19. Coexisting blood disorders over time: A minority of adults with long follow-up later develop plasma-cell disorders; this finding reinforces the MGUS link. SpringerLink

20. Unknown individual susceptibility: Many people have MGUS or viral colds, yet only a few develop ISCLS. Genetic or acquired susceptibility is likely but unproven. American College of Physicians Journals

Symptoms and signs

1. Sudden tiredness and malaise: A common early warning before the leak starts. Yale School of Medicine

2. Fever or flu-like feelings: Often appear in the prodrome. Yale School of Medicine

3. Nausea or stomach pain: Nonspecific early symptoms that should raise suspicion in known patients. Physiopedia

4. Extreme thirst: The body senses low blood volume and asks for fluid. Physiopedia

5. Quick weight gain: Fluid leaves vessels and collects in tissues; weight rises despite low intravascular volume. Physiopedia

6. Swelling of limbs (edema) and tight skin: Especially hands and legs during the leak phase. American College of Physicians Journals

7. Low blood pressure (hypotension) and faintness: A key sign of the attack. American College of Physicians Journals

8. Cold, clammy skin and poor capillary refill: Signs of shock. American College of Physicians Journals

9. Muscle pain and cramps: Tissues become swollen and under-perfused. Compartment pain can appear in severe cases. American College of Physicians Journals

10. Reduced urine output: Kidneys get less blood flow during shock. BioMed Central

11. Confusion or agitation: The brain gets less oxygenated blood when pressure is low. American College of Physicians Journals

12. Shortness of breath (later, in recovery if overloaded): When leaked fluid returns to the bloodstream, lungs and heart may become stressed if fluids were over-given. PMC

13. Chest discomfort or fast heartbeat: The heart works harder during low volume states; ECG monitoring is advised. American College of Physicians Journals

14. Bluish fingers/toes or cool extremities: From reduced perfusion. American College of Physicians Journals

15. Headache and dizziness: Common with low blood pressure and hemoconcentration. American College of Physicians Journals

Diagnostic tests

Important: Doctors use the triad—hypotension, hemoconcentration, and hypoalbuminemia—plus the clinical phases and exclusion of other causes to make the diagnosis. The following tests help confirm the pattern, assess severity, and rule out mimics. American College of Physicians Journals

Physical examination

1. Blood pressure and heart rate at the bedside: Very low pressure with a fast pulse suggests the leak (shock). Repeated readings track response to care. American College of Physicians Journals

2. Capillary refill, skin temperature, and color: Slow refill and cool, pale or mottled skin show poor perfusion during the leak phase. American College of Physicians Journals

3. Limb swelling and tight compartments: Marked edema and pain can signal rising compartment pressures that may need urgent surgical review. American College of Physicians Journals

4. Lung and heart exam: In the early leak, lungs may be clear despite shock (not cardiogenic). Later, during post-leak, crackles can appear if fluid overload develops. PMC

5. Neurologic status (alertness, confusion): Helps judge tissue perfusion and need for intensive monitoring. American College of Physicians Journals

Manual bedside tests and monitoring

6. Orthostatic vitals (with caution): A drop in pressure on standing is unsafe during shock but, when stable, helps show volume depletion. Clinical teams apply judgment and continuous monitoring. American College of Physicians Journals

7. Bedside ultrasound of IVC (by trained staff): A small, collapsing inferior vena cava suggests low intravascular volume in the leak phase; this is a quick, noninvasive check. (Common critical-care practice in shock.) American College of Physicians Journals

8. Compartment pressure measurement (if severe limb pain): Confirms suspected compartment syndrome from massive edema and guides urgent surgery. American College of Physicians Journals

Laboratory and pathological tests

9. Complete blood count (CBC): High hematocrit and hemoglobin show hemoconcentration; white cells and platelets can also rise during attacks. This is part of the classic triad. American College of Physicians Journals

10. Serum albumin and total protein: Low albumin with high hematocrit strongly supports SCLS during an episode. American College of Physicians Journals

11. Basic metabolic panel and creatinine: Checks kidney function, which can worsen during shock; guides fluids and medications. BioMed Central

12. Lactate: Elevated lactate suggests poor tissue perfusion and helps track shock severity and response. American College of Physicians Journals

13. Serum electrolytes (including potassium, sodium): Shifts occur with fluid loss into tissues and with treatment; careful correction is needed. American College of Physicians Journals

14. Serum protein electrophoresis and immunofixation: Looks for monoclonal gammopathy (MGUS), which is common in adult ISCLS and supports the diagnosis. American College of Physicians Journals

15. Inflammatory markers (CRP, sometimes cytokine panels in studies): May rise around attacks and help rule out infection. Research also explores cytokines as triggers. PubMed

16. Cultures and infection work-up when indicated: Because sepsis can mimic SCLS, doctors send blood/urine cultures if infection is possible. ATS Journals

Electrodiagnostic tests

17. Electrocardiogram (ECG): Checks for rapid heart rhythms or ischemia in shock and monitors the heart before, during, and after fluid shifts. American College of Physicians Journals

18. Cardiac telemetry (continuous ECG monitoring): Detects arrhythmias and tracks heart rate trends during resuscitation and the post-leak return of fluid. American College of Physicians Journals

Imaging tests

19. Chest X-ray: Often normal lungs during early leak (because fluid is outside vessels, not inside the lungs). Later films may show fluid overload if excessive IV fluid was given or during post-leak rebound. PMC

20. Echocardiography (ultrasound of the heart): Helps rule out primary heart failure and assesses heart function when blood pressure is low or when overload is suspected during recovery. American College of Physicians Journals

Non-pharmacological treatments (therapies & other measures)

1. Emergency action plan & early recognition — Teach patients and families to spot prodromal flu-like symptoms, swelling, dizziness, and to seek urgent care before shock develops; early labs showing hemoconcentration/low albumin speed diagnosis. rarediseases.org+1

2. ICU monitoring during attacks — Continuous blood pressure, urine output, lactate, electrolytes; attacks can swing quickly from shock to pulmonary edema in the recruitment phase. PMC

3. Conservative, goal-directed fluids in the leak phase — Use small, carefully titrated boluses to maintain organ perfusion; avoid aggressive over-resuscitation to reduce later pulmonary edema risk. BioMed Central

4. Early vasopressor support when needed — If fluids fail to restore pressure, use pressors to maintain perfusion while leakage persists (drug choices in “Drugs” section). PubMed

5. Point-of-care ultrasound (POCUS) — IVC size/variability and lung ultrasound help guide fluids and detect recruitment-phase pulmonary edema early. PMC

6. Leg elevation & compression (recovery phase) — Helps mobilize interstitial fluid back to the circulation more safely; apply judiciously with close monitoring. PMC

7. Compartment pressure checks — Large limb swelling can cause compartment syndrome; measure pressures early if pain out of proportion or tense compartments. Ovid+1

8. Fasciotomy when indicated — Limb-saving surgery for confirmed compartment syndrome (see “Surgeries”). ResearchGate

9. Renal replacement therapy (RRT) when AKI/overload — CRRT or intermittent dialysis supports kidneys and helps manage fluid shifts during severe attacks. Cureus+1

10. Careful diuresis in recruitment phase — Once capillary seal returns and lungs flood, judicious diuretic use and ventilatory support may be needed. BioMed Central

11. Mechanical ventilation if needed — Treat flash pulmonary edema and respiratory failure during recruitment; anticipate rapid changes. American College of Physicians Journals

12. Infection prevention — Vaccinations (e.g., influenza) and prompt infection control may reduce triggers; follow local guidance. Cleveland Clinic

13. Long-term prophylaxis education — Discuss IVIG maintenance (monthly) and alternatives (theophylline/terbutaline) including benefits/limits. PMC+1

14. DVT prophylaxis (mechanical) — Intermittent pneumatic compression/early mobilization when safe; hyperviscosity and immobility increase risk. PubMed

15. Nutrition & graded rehab — After severe attacks, gradual activity and nutrition help restore muscle and function. rarediseases.org

16. Medication alert card/bracelet — Identify ISCLS and typical ICU plan to speed correct management in future emergencies. rarediseases.org

17. Fluid balance charts & daily weights — Track ins/outs closely; sudden weight rise in recruitment suggests impending pulmonary edema. PMC

18. Strict skin care & pressure injury prevention — Massive edema stretches skin; protect to reduce breakdown and infection risk. rarediseases.org

19. Multidisciplinary review (ICU, immunology/hematology) — Coordinate acute care, prophylaxis, and monitoring for monoclonal gammopathy. PubMed

20. Patient registry participation — Centers tracking ISCLS improve knowledge and outcomes; consider referral/registry enrollment when possible. PubMed

---

Drug treatments

(SCLS uses are often off-label; doses below reflect on-label indications from FDA prescribing information, then I explain the off-label rationale for ISCLS. Always individualize in ICU.)

1. IVIG (immune globulin intravenous, 10%—e.g., Privigen, Gammagard Liquid)
   Class: Polyclonal IgG. Dose (on-label): Replacement and immunomodulatory regimens vary by indication (e.g., 2 g/kg for ITP, divided dosing for CIDP). Purpose in ISCLS: Monthly prophylaxis to prevent attacks; multiple series show large reductions in attack frequency and severity. Mechanism: Stabilizes endothelium and neutralizes inflammatory mediators/paraprotein interactions (proposed). Key risks: Thrombosis, hemolysis, renal dysfunction (product boxed warnings). criteria.blood.gov.au+4U.S. Food and Drug Administration+4U.S. Food and Drug Administration+4

2. Terbutaline (β2-agonist)
   Class: Short-acting β2-adrenergic agonist. Dose (on-label examples): For bronchospasm; dosing varies by formulation (U.S. label details are limited publicly; see FDA guidance and international PIs). Purpose in ISCLS (off-label): Oral or injectable prophylaxis sometimes used when IVIG is unavailable/not tolerated. Mechanism: Raises intracellular cAMP in endothelium/smooth muscle, potentially tightening endothelial junctions. Key risks: Tremor, tachycardia; obstetric use safety warnings. FDA Access Data+2U.S. Food and Drug Administration+2

3. Theophylline (methylxanthine)
   Class: PDE inhibitor/adenosine antagonist. Dose (on-label examples): Doses titrated to serum levels for bronchospasm (see FDA label). Purpose in ISCLS (off-label): Oral prophylaxis alone or with terbutaline when IVIG not used. Mechanism: Increases cAMP, possibly improving endothelial barrier; requires level monitoring. Key risks: Narrow therapeutic index; arrhythmias, seizures with toxicity; many drug interactions. FDA Access Data+1

4. Epinephrine (IV infusion)
   Class: Mixed α/β catecholamine vasopressor. Dose (on-label for shock): Titrated IV infusion per label. Purpose in ISCLS: Treat leak-phase refractory hypotension to maintain perfusion. Risks: Arrhythmias, ischemia; requires central line/ICU monitoring. FDA Access Data+1

5. Norepinephrine (IV infusion)
   Class: Predominant α-agonist with β-1 activity; first-line pressor in many shocks. Purpose: Leak-phase hypotension. Risks: Extravasation/ischemia; titrate carefully. FDA Access Data+1

6. Phenylephrine (IV infusion or premix)
   Class: Pure α-1 agonist. Purpose: Alternative/adjunct vasopressor when tachyarrhythmia limits catecholamines. Notes: Label supports use in vasodilatory hypotension. FDA Access Data+1

7. Vasopressin (IV infusion)
   Class: Non-catecholamine vasoconstrictor. Purpose: Add-on to catecholamines in vasodilatory shock to reduce catecholamine dose and support MAP. Risks: Ischemia at high doses. FDA Access Data+2FDA Access Data+2

8. Hydrocortisone (IV)
   Class: Glucocorticoid. Purpose in ISCLS: Sometimes used during attacks for potential capillary-stabilizing/anti-inflammatory effects, though evidence is limited; consider if concurrent adrenal insufficiency or refractory shock. Risks: Hyperglycemia, infection risk. (General critical-care steroid practice; ISCLS-specific benefit uncertain.) PubMed

9. Methylprednisolone (IV)
   Class: Glucocorticoid. Purpose: Some case reports/series use; efficacy inconsistent; not first-line prophylaxis compared with IVIG. Risks: Same steroid class effects. PubMed

10. Albumin (Human) 25% (IV)
    Class: Colloid. Purpose: In selected patients, small, cautious albumin doses may help restore oncotic pressure after leak abates; must avoid fluid overload in recruitment phase. Risks: Volume overload; product is plasma-derived with standard viral safety steps. U.S. Food and Drug Administration+1

11. Diuretics (e.g., furosemide, IV)
    Class: Loop diuretic. Purpose: Manage recruitment-phase pulmonary edema after capillary seal returns. Note: Use only when intravascular volume is replete to avoid hypotension. BioMed Central

12. Antimicrobials (empiric as indicated)
    Class: Various. Purpose: If infection is suspected trigger or differential includes sepsis, treat per local sepsis protocols while confirming ISCLS. Note: Not ISCLS-specific but common in evaluation. Cleveland Clinic

13. Anticoagulation (DVT prophylaxis with heparin/LMWH)
    Purpose: Consider pharmacologic DVT prophylaxis when bleeding risk is acceptable, given hemoconcentration/immobility; tailor to patient. PubMed

14. Subcutaneous immunoglobulin (SCIG)
    Class: Polyclonal IgG. Purpose: Maintenance prophylaxis alternative to IVIG; small series suggest benefit in relapse prevention. Notes: Not universally available; dosing individualized. American Journal of Medicine

15. Beta-agonist nebulizers (supportive)
    Purpose: Symptom relief if coexisting reactive airways; not disease-modifying for ISCLS but can aid comfort. FDA Access Data

16. Vasopressor weaning protocols
    Purpose: Safe tapering as leak resolves to avoid recrudescence of hypotension; follow label guidance on gradual dose reductions. FDA Access Data

17. Electrolyte repletion (e.g., potassium, magnesium)
    Purpose: Correct β-agonist/theophylline-related shifts and protect against arrhythmias. Note: Supportive, protocol-driven ICU care. FDA Access Data

18. Aminophylline (IV)
    Class: Theophylline prodrug. Purpose: Some centers use during prophylaxis transitions; same cautions as theophylline. PubMed

19. Adjunct anti-cytokine/immune agents (highly selective cases)
    Case reports mention agents like infliximab or thalidomide in refractory cases; evidence is limited and not standard. PubMed

20. Avoid hydroxyethyl starches (HES)
    Note: Colloid resuscitation with HES is associated with renal risk and is not recommended; prefer cautious crystalloids/albumin. SpringerLink

Most effective long-term prophylaxis: Monthly IVIG has the best evidence for reducing attacks; β2-agonist/theophylline regimens are considered when IVIG isn’t feasible. PMC+2criteria.blood.gov.au+2

---

Dietary molecular supplements

No supplement is proven to prevent Clarkson disease attacks. Any use should be adjunctive and discussed with your clinician. Short notes below summarize physiologic rationale only. PubMed

1. Vitamin D — Supports immune balance; deficiency correction is reasonable per general health guidance, but no ISCLS-specific trial exists. PubMed

2. Omega-3 fatty acids — Anti-inflammatory effects; no ISCLS-specific data. PubMed

3. Vitamin C — Endothelial cofactor roles suggested in critical-care literature; ISCLS-specific benefit unproven. PubMed

4. Thiamine — Helpful in shock states if deficient; no ISCLS-specific trial. PubMed

5. Magnesium — Correct deficiency to reduce arrhythmias with β-agonists/theophylline; not ISCLS-specific. FDA Access Data

6. Zinc — General immune support; no ISCLS data. PubMed

7. Coenzyme Q10 — Mitochondrial cofactor; no ISCLS data. PubMed

8. Selenium — Antioxidant roles; no ISCLS studies. PubMed

9. L-carnitine — Energy metabolism; no ISCLS studies. PubMed

10. Probiotics — Gut-immune axis interest; no ISCLS evidence. PubMed

---

Immunity booster / regenerative / stem-cell drugs

There are no approved stem-cell or regenerative drugs for Clarkson disease. Below are research-adjacent or supportive concepts sometimes discussed; these are not proven disease treatments and should not replace IVIG-based prophylaxis. PubMed

1. IVIG as immune modulation — Strongest evidence to prevent recurrences; immunomodulatory rather than “regenerative.” PMC

2. SCIG (home-based immunoglobulin) — Alternative route for maintenance immune modulation; limited series suggest benefit. American Journal of Medicine

3. High-dose steroids (short course in crises) — Sometimes used for inflammation control; not disease-modifying; mixed evidence. PubMed

4. TNF-α blockers (e.g., infliximab) — Only anecdotal reports in refractory cases; not standard. PubMed

5. Thalidomide/lenalidomide — Case reports only; potential toxicity; specialist use only if research-driven. PubMed

6. Future endothelial-stabilizing biologics — Research interest exists, but no approved agent yet; management remains supportive plus IVIG prophylaxis. PubMed

---

Surgeries (procedures & why they’re done)

1. Fasciotomy for limb compartment syndrome — Massive limb swelling can dangerously raise compartment pressures, threatening nerves and muscles; emergency fasciotomy relieves pressure and saves function/life. Ovid+2ResearchGate+2

2. Airway intubation — Not surgery but an invasive procedure; used for respiratory failure or severe pulmonary edema during recruitment. American College of Physicians Journals

3. Central venous catheter placement — For vasopressors and precise hemodynamic/volume management in ICU. PubMed

4. Dialysis catheter insertion — For renal replacement therapy in severe AKI or fluid management problems. Cureus

5. Escharotomy/limb-saving decompression variants — Rarely, when skin becomes too tight or non-elastic and compromises circulation, surgeons may use related decompression procedures. SAGE Journals

---

Preventions

1. Discuss monthly IVIG prophylaxis as first-line prevention when suitable; strongest evidence base. PMC

2. Have an emergency plan for prodromes with a wallet card describing ISCLS, your baseline labs, and ICU care preferences. rarediseases.org

3. Treat infections early and keep routine vaccinations updated per clinician advice (e.g., influenza). Cleveland Clinic

4. Avoid dehydration and extreme exertion when unwell. rarediseases.org

5. Medication review for agents that worsen tachycardia/arrhythmia risk if you’re on theophylline/β-agonists. FDA Access Data

6. Regular follow-up for monoclonal gammopathy (MGUS monitoring). PubMed

7. Educate family/caregivers to recognize early signs and call emergency services promptly. rarediseases.org

8. Travel/clinic letter explaining ISCLS and preferred hospital. rarediseases.org

9. Healthy lifestyle basics (sleep, nutrition, hydration) to reduce general illness triggers. Cleveland Clinic

10. Registry participation/center of excellence where possible. PubMed

---

When to see a doctor

Seek urgent care immediately for flu-like prodrome plus limb swelling, dizziness, fainting, chest discomfort, shortness of breath, very little urine, or new severe pain and tightness in a limb (possible compartment syndrome). Tell clinicians you may have Clarkson disease, and show your alert card if you have one. ICU care is often required because patients can crash quickly in the leak phase and then develop pulmonary edema in the recruitment phase. rarediseases.org+1

---

What to eat and what to avoid

During recovery, eat normal balanced meals with adequate protein and fluids as advised by your team; avoid extreme salt loads if you’re fluid-overloaded, and avoid stimulants that may worsen tachycardia if you take β-agonists/theophylline. There is no proven “ISCLS diet,” but steady hydration and avoiding alcohol binges or energy drinks is reasonable. In acute attacks, nutrition is guided by your ICU team. FDA Access Data

---

Frequently asked questions

1. Is Clarkson disease genetic or infectious?
   No clear genetic or infectious cause is proven; many have a small monoclonal gammopathy (MGUS). PubMed

2. How is an attack diagnosed?
   By the triad: hypotension, hemoconcentration, hypoalbuminemia, after ruling out sepsis/anaphylaxis/heart failure. PMC

3. What is the best prevention?
   Monthly IVIG has the most supportive evidence; β2-agonist/theophylline regimens are alternatives. PMC+1

4. Are big fluid boluses good?
   No. Use cautious, goal-directed fluids—over-resuscitation raises the risk of later pulmonary edema. BioMed Central

5. Why do lungs suddenly flood later?
   When capillaries “reseal,” interstitial fluid reenters the bloodstream (“recruitment”), precipitating flash pulmonary edema. PMC

6. Can limbs be permanently damaged?
   Yes—severe swelling can cause compartment syndrome, needing urgent fasciotomy. Ovid

7. Can kidneys fail?
   Yes—shock, myoglobin, and hemoconcentration can cause AKI; dialysis may be needed temporarily. Cureus+1

8. Is IVIG safe?
   IVIG is widely used but carries risks (thrombosis, renal dysfunction); risk mitigation and selection of product/dose are important. U.S. Food and Drug Administration

9. Do steroids cure it?
   No. Steroids may be tried in some settings but are not proven to prevent recurrences compared with IVIG. PubMed

10. What pressors are used in shock?
    Norepinephrine, epinephrine, vasopressin, phenylephrine are ICU options per shock labels; choice is individualized. FDA Access Data+3FDA Access Data+3FDA Access Data+3

11. Can subcutaneous immunoglobulin work?
    Small series suggest SCIG can maintain prophylaxis when IVIG is impractical. American Journal of Medicine

12. Is there a cure?
    No cure yet; prevention (IVIG) and expert acute care have greatly improved outcomes. PMC

13. Where can I read more medical details?
    Comprehensive reviews by Druey/colleagues and Orphanet/NORD give clinician-level details. rarediseases.org+3PubMed+3PMC+3

14. What about COVID-19 links?
    Secondary/triggered capillary leak can occur with infections including SARS-CoV-2; management principles are similar. revistasccot.org

15. Are outcomes improving?
    Yes—recognition and IVIG prophylaxis appear to reduce attacks and related mortality in cohorts. PMC+1

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: November 10, 2025.